本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Enliven Treateutics

53.36
-1.0700-1.97%
盤後53.360.00000.00%16:51 EDT
成交量:86.70萬
成交額:4,627.63萬
市值:39.10億
市盈率:-31.85
高:54.50
開:54.32
低:52.98
收:54.43
52周最高:62.32
52周最低:14.79
股本:7,327.08萬
流通股本:6,172.59萬
量比:0.83
換手率:1.40%
股息:- -
股息率:- -
每股收益(TTM):-1.6753
每股收益(LYR):-1.8300
淨資產收益率:-15.31%
總資產收益率:-11.00%
市淨率:4.37
市盈率(LYR):-29.16

資料載入中...

2024/03/14

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/14

重要事件披露

Form 8-K - Current report
2024/03/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/16

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]